Tarzena Capsules 0.1mg, manufactured by Pfizer, contains Talazoparib (YJ code: 4291081M1022, standard: 0.1mg 1 capsule). This poly ADP-ribose polymerase (PARP) inhibitor is used to treat advanced breast cancer with germline BRCA mutations and homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer, by preventing DNA repair and leading to synthetic lethality in cancer cells.
Tarzena Capsules 0.1mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
